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ABSTRACT

THE ROLE OF OMPD IN ADHERENCE OF SALMONELLA ENTERICA SEROVAR
TYPHIMURIUM TO MACROPHAGES AND THE EFFECT OF MANNAN-BINDING
LECTIN IN INITIAL ATTACHMENT
by
Donna Terrio
University of New Hampshire, September, 2008

The binding of macrophages to the outer membrane porin proteins,
OmpC and OmpD, a n d the effects of mannan-binding lectin (MBL) were
investigated. MBL was isolated from pig serum in a multi-step affinity
chromatography process and the purity of the samples was determined
via sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDSPAGE) under reducing conditions. An Immunoglobulin G (IgG) EnzymeLinked Immunosorbent Assay (ELISA) was used to detect MBL. Porcine
MBL was present in serum in approximately 30,32 a n d 34 kDa monomeric
forms. Bacterial binding assays were performed using Salmonella
enterica serovar Typhimurium wild-type, ompC- deficient a n d ompDdeficient bacterial strains. These experiments were repeated in the
presence of increasing concentrations of either porcine or human MBL.
x

Adherence of U937 cells to both the wt and ompC- deficient strains
increased in a dose dependent manner. In contrast adherence of U937
cells to the ompD- deficient strain did not change significantly in the
presence of either porcine or human MBL. Inhibition assays using an antiMBL monoclonal antibody supported these results. We conclude that the
outer membrane protein D mediates the attachment of U937 cells and
that MBL influences OmpD adherence to this macrophage cell line.

XI

INTRODUCTION

Salmonella infections continue to pose a serious threat to public health
a n d agriculture. During recent years there has been a sharp increase in
bacterial resistance to antibiotics making it ever more difficult to treat and
prevent infection. In the United States alone, nontyphoidal Salmonella is
responsible for approximately 1.4 million foodborne infections each year
and accounts for more deaths than d o infection with any other
foodborne bacterial pathogen (16). In addition, the increase in
Salmonella infections has had an economic impact. In the human
population, the estimated annual costs related with Salmonella infections
are $0.5-$3.2 billion/year (15).

There are over 2500 known Salmonella enterica serovars, producing
distinct disease symptoms in different animals. Salmonella

enterica

serovar Typhimurium a Gram-negative facultative anaerobe, produces
gastroenteritis in humans a n d typhoid-like disease in mice (1). On the
other hand, Salmonella enterica serovar Typhi grows exclusively in
humans, causing typhoid fever (17). Salmonella is transmitted primarily via
the oral route by ingestion of contaminated water or animal products.
The infective dose for humans is approximately 10 6 -10 8 colony forming
1

units (CFU), although in many cases it has been shown to be substantially
lower (39). The onset of disease can be anywhere between 5-20 days.
The variance is due to several factors, including the number of bacteria
ingested and the health of the individual (40).

Orally ingested Salmonella penetrate the intestinal mucosa migrating
through specialized M cells (2), where they interact with macrophages.
During bacterial infection, macrophages serve as professional phagocytes
and key effectors of the innate and adaptive immune responses (14).
Although macrophages are important host defense cells. Salmonella
Typhimurium has been shown to benefit from the macrophage's
phagocytic actions. Salmonella is able to reside intracellular^, where it
can replicate inside specialized vacuoles within macrophages (3). Studies
have shown that the growth rate of the bacteria within these vacuoles
changes over time and is affected by the rapid acidification of the
vacuole (40,41). If acidification is prevented then the bacteria cannot
multiply, although they are able to survive (41). Therefore, the antimicrobial acidification process allows time for the bacteria to propagate
and greatly affects the outcome of disease.

Macrophages have developed specific receptors that recognize
2

certain conserved motifs on pathogens. For example, the mannose
receptor recognizes and preferentially binds to carbohdrates containing
either mannose or fucose (25). It has been proposed that this
carbohydrate-specific receptor is part of a primitive immune recognition
system (5). There are other macrophage receptors, such as the
scavenger receptors, that have also been found to bind mannose (8,9).
However, for most of these molecules, the nature of the receptor and the
signaling pathways they use remain undefined.

Mannan-binding lectin (MBL), a C-type lectin, also recognizes and
binds to sugars on microbial cell surfaces. Binding of MBL and its
associated serine proteases, MASP-1 and MASP-2, activates the lectin
complement pathway (4,5). There are two additional MASPs, MASP-3 and
MASP-4, but very little is presently known about their function ( 4,9). These
enzymes are able to cleave C4 and C2 to form C4bC2a, a C3 convertase
that enzymatically splits numerous molecules of C3 into C3a a n d C3b
(5,6,9). Small fragments produced during the cleavage of the
complement proteins act as chemokines and recruit phagocytes to the
area. Finally, the terminal components of complement bind together and
attach to the bacterial membranes, resulting in the formation of pores
and the lysis of the bacteria (8). MBL may also interact directly with
3

phagocytic cells to promote the opsonization of bacteria. That is, it may
influence phagocytosis in the absence of complement activation through
an interaction with one or more collectin receptors (3,6,8). The latter
relationship was the focus of the current study.

The immune response to bacterial infection is initiated by the ability of
the host to recognize pathogen-associated molecular patterns (PAMPs)
on bacterial cell surfaces (7,28,36). Host cells discriminate between self
and non-self through families of bacterial binding receptors that are
designed to recognize a few highly conserved structures present in many
different microorganisms (36,40). These receptors are called pattern
recognition receptors (PRRs). PRRs become activated in response to
binding specifically to PAMPs (4,25,26). Because different pathogens
express their own array of PAMPs, the host has evolved multiple PRRs to
recognize specific microbial motifs (3,4,26,28,36), The repeating sugar
units located on the cell surface of Salmonella Typhimurium form a
specific three dimensional pattern (7,28). It is this defined motif that
mannan-binding lectin recognizes (4,9,26).

While Salmonella has been shown to express a large array of virulence
factors, evidence suggests that microbial outer membrane porin proteins
4

are key surface associated molecular complexes involved in initial
recognition of pathogens by host cells (11,12). Porins exist as either homoor heterodimers and are involved in transport of small hydrophilic
compounds into and out of the cell (7,10,11). These proteins play an
essential role in the survival of the cell, and their study is of great interest
with respect to potential medical applications. Porins will be discussed in
greater detail later in this report.

The overall goal of this project was to help elucidate the "cross-talk"
involved during the early infection process between Salmonella
Typhimurium and host cells. The following objectives were designed to
meet this goal. The first objective was to determine whether MBL
enhances the adherence of human macrophages to Salmonella.
Previously in our lab, porcine serum had been partially purified in an
attempt to isolate MBL. However, a more purified sample was needed to
continue research on this project. Therefore, the goal here was to
develop an assay that would separate MBL from other proteins in the
serum. Then a series of binding assays were performed using the purified
porcine MBL, human MBL, and Salmonella. The goal was to determine
whether MBL enhances macrophage attachment, engulfment and
internalization of the bacteria.

5

The second objective was to determine whether outer membrane
proteins - porins - are involved in macrophage recognition by
salmonellae. Comparative studies were performed using a wildtype
parent strain and two different mutants deficient in a specific porin: 1) an
ompC- deficient strain (ompC::Tn/0); and, 2) an ompD- deficient strain
, (ompD::Tn5). Microbial attachment in both studies was determined
visually by light microscopy.
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CHAPTER ONE

CHAPTER 1
Isolation of Mannan-Binding Lectin
from Porcine Serum

ABSTRACT
Author: Terrio, Donna
Type of Publication: Unpublished

Mannan-binding lectin (MBL) is a C-type lectin that recognizes and
binds to carbohydrates on bacterial cell surfaces. Human MBL has been
characterized and extensively studied, however, very little is known about
porcine MBL. In this study, pig MBL was isolated by a multi-step affinity
chromatography process and the purity of the samples was determined
via SDS-PAGE under reducing conditions and an Immunoglobulin G (IgG)
Enzyme-Linked Immunosorbent Assay (ELISA). It was found that porcine
MBL is present in serum in forms with a reduced molecular mass of
approximately 30, 32 and 34 kDa.
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INTRODUCTION

The shortage of human donor organs and tissues for transplantation
has led researchers to consider xenotransplantation as a therapeutic
option. Large advances have been made in the use of certain pig tissues
in human transplants. However, rejection of these tissues has remained an
obstacle. Pig organs have certain epitopes which are recognized by
specific human antibodies. This c a n induce a hyperacute rejection by
triggering the complement cascade, which involves the protein mannanbinding lectin (MBL). Presently very little is known about the function of
porcine mannan-binding lectin (pMBL). The study of pMBL may aid in the
development of strategies to circumvent xenograft rejection.

The primary structure of human MBL (hMBL) is a 96 kDa helical molecule
(23,24). It is comprised of three identical 32 kDa chains. Each monomer
consists of a "cysteine-rich" N-terminal region, followed by a collagenous
region, a "neck" region, a n d finally a C-terminal carbohydraterecognition domain (CRD), where the binding of sugars on microbial cell
surfaces occurs (9,18,21). In addition, studies have shown that during
9

sodium didecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE),
under reducing conditions, pMBL separates into three bands with
approximate molecular masses of 30, 32, and 34 kDa (20). In contrast,
similar experiments have shown that hMBL reduces to a single 32 kDa
band (21).

Previous studies in our laboratory have shown that pMBL mediates
attachment of Salmonella Typhimurium to human U937 macrophage cells
(I. Daniels, thesis). However, the MBL was incompletely purified, i.e., the
final sample was contaminated with IgG. Since IgG is able to enhance
the binding of bacteria to macrophages, it was not known whether MBL,
IgG, or both 'mediated the attachment. Therefore, prior to the onset of
the binding assays discussed later in chapter 2, a method was developed
to further purify the MBL.

In this study, pMBL was isolated by a multi-step affinity chromatography
process and the purity of the samples was determined via SDS-PAGE
under reducing conditions and an Immunoglobulin G (IgG) EnzymeLinked Immunosorbent Assay (ELISA). A mannan-agarose column was
used during Phase 1 of the purification process. The eluted Phase 1
fractions contained MBL as well as IgG (fig. 1.1). To extract these
10

immunoglobulins from the sample a protein A-agarose column was used
during Phase 2 of the purification process. Protein A is a protein found on
the surface of Staphylococcus aureus strains that binds specific subsets of
immunoglobulins. It has been proposed that binding of host
immunoglobulins helps camouflage the bacterium from the immune
system.

11
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Fig. 1.1. Schematic representation of the binding of MBL, IgG and IgM
during affinity purification on mannan-agarose. MBL and IgG both have
an affinity toward mannan and thus bind to the mannan-agarose beads
in the column in Phase 1 of the purification process. In addition, IgM has
an affinity towards MBL. Therefore, the Phase 1 fractions contained MBL as
well as IgG and IgM.
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MATERIALS AND METHODS

Chemicals. All chemicals used were obtained from Sigma-Aldrich
Company (St. Louis, MO), except where otherwise noted.

Porcine serum stock. Pig serum was generously donated by Dr. D.
Bobilya (UNH, Durham, NH).

Chromatography Supplies. All equipment used in the purification
process was obtained from Bio-Rad (Hercules, CA), unless otherwise
noted.

Anti-IgG antibody. An anti- porcine IgG antibody ELISA was used
(Alpha Diagnostic International, Inc., San Antonio, TX).

Isolation of MBL from pig serum. Phase ?. The purification process was
carried out at 4 °C, except where otherwise stated. A pool of porcine
serum, after addition of polyethylene glycol (PEG) 3350 to 10% (w/v), was
stirred for 2 h. Precipitated proteins were pelleted by centrifugation for 10
min. at 8000 g. The pellets were dissolved in TBS-TCa2+ buffer (50 mM
Tris/1 M NaCI/20 mM CaCI 2 /0.05% Tween 20, pH 7.8), and insoluble
13

materials were removed by centrifugation for 5 min at 8000 g. The
supernatant was mixed for 2 h with 10 ml of mannan-agarose that was
previously equilibrated with TBS-TCa2+. The resin was recovered by
centrifugation for 5 min. at 1000 g and packed into a column after
washing with TBS-TCa2+. The column was further washed with 200 ml of
TBS-TCa2+ a n d then eluted with TBS-TEDTA (TBS-TCa2+ where 20 mM CaCI 2
was replaced with 10 mM EDTA). The EDTA eluate was made 40 mM with
respect to CaCb and reapplied to the column. After washing the column
with TBS-TCa2+, bound proteins were eluted with 100 mM mannose in TBSTCa2+. MBL-containing fractions, as judged by SDS-PAGE, were pooled. A
separate aliquot was saved for later analysis (to be compared to the final
purified MBL).

ISOLATION OF MBL Phase 2. The pooled MBL- containing sample was
first applied to a desalting column since high salt concentrations may
increase non-specific binding. To elute the proteins, binding buffer (80%
glycine, 20% sodium chloride, pH 9.0) was a d d e d . The eluate was
collected a n d applied to a protein-A agarose column. The protein A
column consists of purified protein A coupled to crosslinked agarose
beads. The protein A column was designed to purify IgG. However, in our
research w e used the protein-A agarose beads to bind the IgG that
14

remained in the crude MBL sample (Phasel), while allowing the MBL to
pass through, hence, purifying the MBL. The fractions containing the MBL
were saved for further analysis.
After washing the column with binding buffer (80% glycine, 20% sodium
chloride, pH 9.0) two times, any IgG that had adhered to the beads was
removed with an elution buffer (65% citric acid, 35% trisodium salt
dehydrate, pH 3.0). The eluate was collected and saved for further
analysis. The collected samples were concentrated in an Apollo20
concentrator and washed with TBS-TCa2+, pH 7.8, at 1200 g, for 15 min.
This step was repeated three times.

BRADFORD-LIKE ASSAY. To determine protein concentration in the
samples a Bio-Rad protein assay was performed according to the
protocol provided by the company. Briefly, Bio-Rad protein dye reagent
was diluted and filtered just prior to use. Bovine Serum Albumin (BSA)
standards were prepared containing a range of 20 to 400 micrograms of
protein in 100 pi volumes, in separate 15 ml tubes. Diluted dye reagent (5
ml) was added to each tube and incubated for approximately 5 minutes
and absorbance was read at 590 nm. To create a standard curve the
absorption readings were plotted on a graph and an R-value was
generated by which the unknown samples were analyzed.
15

SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL ELECTROPHORESIS

(SDS-PAGE). SDS-PAGE was carried out using a phosphate buffer system
as described by Laemmli (45). The total polyacrylamide concentration
was 12% for the separating gel. One volume from each purified sample
was a d d e d to one volume of sample buffer (1:1). To examine proteins
under reducing conditions, samples were heated for 5 minutes at 90°C in .
the presence of 50 mM dithiothreitol. A low molecular weight (LMW)
standard marker from Bio-Rad was used. SDS-PAGE was performed at a
constant voltage of 200. Silver stain was used to visualize the protein
bands.
The protein concentrations that were determined in the Bio-Rad
protein assay were based on the total protein in each sample. Since the
Phase 1 sample should have contained both MBL and IgG it was not
known how much of the total protein was MBL and how much was IgG.
Therefore, to find comparative MBL and IgG concentrations a series of
gels were run using varying protein concentrations from the Phase 1 and
Phase 2 samples. Gels were then run using the established protein
concentrations.
Approximately 25 pg total protein of the Phi sample was applied to
these latter gels and approximately 15 pg total protein of the Phase 2
samples was applied. Lastly, to further determine the purity of the Phase 2
16

MBL sample, decreasing protein concentrations were loaded into one
gel.

SILVER STAINING SDS-PAGE GELS. For visualization purposes, gels were
silver stained per the protocol supplied by the company (Bio-Rad). Briefly,
all steps were completed at room temperature a n d were under constant
shaking conditions. Working solutions were prepared no longer than 24
hours prior to use. Gels were first fixed for 30 minutes in a fixing solution,
then removed a n d placed in a sensitizing solution and incubated for 30
minutes. Gels were washed three times for 5 minutes in dhhO, then
placed in silver staining solution and incubated for 20 minutes. The gels
were washed twice for 1 minute, and placed in a developing solution until
bands appeared (-1-5 minutes). Finally, the reaction was stopped by
placing gels in a stopping solution for 10 minutes and washed three times
for 5 minutes, then sealed in Kodak photographic clear plastic film.

IMMUNOGLOBULIN G (IgG) ENZYME-LINKED IMMUNOSORBENT
ASSAY(ELISA). 96-well plates pre-coated with anti-porcine IgG antibody
were incubated with varying concentrations of IgG at 37°C. Plates were
washed three times with PBS buffer containing 0.5% Tween-20. IgG was
detected by addition of anti-pig IgG-horseradish peroxidase conjugate to
17

each well and incubated at 20°C for 1 hr. The plates were washed four
times and 50 pi of 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic) acid
(ABTS) was added to each well and the plates were read at 405 nm using
a microplate reader. All ELISA experiments were performed in triplicate
and the mean average was calculated for each experimental condition.

18

RESULTS

Determining protein concentration of the potential MBL-containing
fractions. Two separate Bio-Rad protein assays were performed to
determine total protein concentration of the phase one and phase two
samples. The first protein assay analyzed the Phase 1 sample a n d the
second assay analyzed the two separate Phase 2 samples. The samples
were measured on a spectrophotometer and absorption was read at 595
nm. The BSA standards were plotted a n d a y-formula was generated,
whereby protein concentration was calculated. The R2 was the fraction
of the total squared error. The R2 value was above 0.95 in both
experiments, indicating a g o o d model. The data were collected and the
protein concentration was compared between the two samples. The
Phase 1 fraction contained ~177 pg of protein/ml (Fig. 1.2). The Phase 2
sample contained approximately 23.6 |jg of protein/ml (Fig. 1.3).

19

Bradford-like Protein Assay

-•— standards
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y = 1.7562x+0.6319
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Fig. 1.2. Protein concentration determination of the Phase 1 MBL sample.
The absorption values of the BSA standards were measured at 595 nm and
plotted. The protein concentration of the samples were determined by
using the generated formula. The R2 value above was approximately
0.99. Absorbance was read on three samples. The average absorbance
reading was 0.943. Protein concentration for the Phase 1 sample = 177
Mg/ml.
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Fig. 1.3. Protein concentration determination of the Phase 2 MBL sample.
Absorptiorv of the BSA standards was measured at 595 nm and plotted on
a graph. The protein concentration of the MBL Phase 2 sample was
determined by using the generated formula as done in Fig. 1.2.
Absorbance was read on three samples and the average absorbance
value was 0.236. The protein concentration for the MBL Phase 2 sample =
23.6 MQ/ml.
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Determining purity of the MBL-containing samples via SDS-PAGE. The
purity of each chromatographic fraction was analyzed by SDS-PAGE
under reduced conditions (fig. 1.4 and 1.5). On figure 1.4, lane 1
contained the low molecular weight marker proteins. Lane 2, contained
pooled fractions from the first chromatography step (Phase 1). Lane 3
corresponds to the pooled MBL-containing fractions obtained from Phase
2. Lane 4 contains the IgG from the elution step in Phase 2.
On figure 1.4 the distinct polypeptide bands show a molecular weight
of about 50-kDa which corresponds to pig IgG heavy chains. Also, the
band at molecular weight of approximately 25 kDa corresponds to pig
IgG light chains. There are bands at approximate molecular weights of
30, 32, and 34 kDa corresponding to the three monomeric forms of pig
MBL
The series of arrows across the top portion of the gel on fig. 1.4 points to
the 50 kDa location. Lane 2 shows a band at this location indicating the
presence of IgG heavy chain. Lane 3 shows the deletion of that band in
the Phase 2 sample, indicating that the IgG was extracted from the Phase
1. Lane 4 shows the presence of the 50 kDa band in the Phase 2-lgG
sample.
The series of arrows across the bottom portion of the gel on fig. 1.4
points to the 25 kDa location. Lane 2 shows a band at this location
22

indicating the presence of IgG light chain, in the partially purified MBL
sample (Phase 1). Lane 3 shows the deletion of this band in the more
purified MBL sample from Phase 2. Lane 4 shows the presence of IgG light
chain in the fractions eluted from the IgG column at the end of the Phase
2 process.
To further determine the purity of the Phase 2 MBL sample, decreasing
protein concentrations were loaded into one gel (fig. 1.5).
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Fig. 1.4. SDS-PAGE gel analysis of the Phase 1 and Phase 2 samples. The
arrows across the top designate the 50 kDa IgG band. The bottom arrows
designate the 25 kDa IgG light chain band. Lane 6 (Phase 2 MBLcontaining sample) shows the disappearance ot the 50 kDa IgG heavy
chain and the 25 kDa IgG light chain. Both chains are present in lane 8
(the IgG-containing sample captured during Phase 2). The bands in each
well at ~ 66 kDa are most likely MBL associated serine proteases (MASPs).
Proteins were separated with 12% polyacrylamide gel and visualized by
silver staining.

24

pg of protein:
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kDa
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Lane:

Fig. 1.5. SDS-PAGE (2-mercaptoetanol reduced) analysis of purified
Phase 2 porcine MBL and associated serine proteases (MASPs). The
lanes contained decreasing concentrations of protein ranging from 20 pg
to 5 pg of total protein. The arrow indicates the ~ 66 kDa MASPs. The
bottom 3 bands are the MBL bands at ~ 30,32, and 34 kDa. Proteins
were separated with 12% polyacrylamide gel and visualized by silver
staining. Lanes 2 and 5 remained empty. All lanes are from the same gel.
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Determining the presence of IgG in the phase 2 fractions via
anti-IgG antibody ELISA. To verify that IgG was extracted from the MBL
sample during Phase 2 of the purification process an ELISA was performed.
Protein samples were added to wells pre-coated with anti-pig IgG
antibody. The anti-porcine polyclonal antibody recognized porcine IgG
in the samples. The Phase 1 sample showed the highest concentration of
IgG present at 88.4 pg/ml. The Phase 2 MBL-containing sample showed a
sharp decrease in IgG concentration at 0.24 [jg/ml. The IgG-containing
fraction collected during Phase 2 showed a significant concentration of
IgG, at 27.43 |jg/ml. These results support the SDS-PAGE data, and verify
that IgG was extracted from the MBL-containing Phase 2 sample.

26

IgG ELISA

§

Protein Cone.

1
Protein Samples

Fig. 1.6. IgG ELISA analysis of protein samples collected during Phase 1
and Phase 2 of the purification process. Protein samples were added to
wells pre-coated with anti-porcine IgG antibody. The Phase 1 sample
showed the highest concentration ot IgG at 88.4 pg/ml (#1). The Phase 2
MBL-containing sample (#2) showed a sharp decrease in IgG
concentration at 0.24 pg/ml. The IgG-containing fraction collected
during Phase 2 (#3), showed a significant concentration of IgG at 27
jjg/ml, verifying that IgG was extracted from the Phase 1 sample.
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DISCUSSION
Previously in our lab, porcine MBL was partially purified by a 2-step
chromatography process (I. Daniels, thesis). In the current study this
portion of the purification process was further developed and designated
Phase 1. To isolate MBL a subsequent assay was developed and
designated Phase 2. A column packed with mannan-agarose was used
to purify MBL during Phase 1. Electrophoresis gel analysis showed
impurities at this stage. Due to its affinity to mannan IgG was thought to
be a possible contaminant. Therefore, the goal was to develop an assay
that would remove the possible IgG contaminant, resulting in a more
purified MBL sample. Since protein A has an affinity towards porcine IgG
a Bio-Rad protein-A column was used to remove the IgG from the Phase 1
sample.
SDS-PAGE analysis revealed the presence of three monomeric forms of
porcine MBL with approximate molecular masses of 30, 32 and 34 kDa.
These data support previously published observations by Agah et al. (20).
In contrast, human MBL has been characterized and shown to exist in a
single isoform (4,23,24) with an approximate molecular mass of 32 kDa.
Interestingly, Agah and colleagues also suggested that the three porcine
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monomeric isoforms isolated by their methods are a single protein with
post-translational modifications.

Electrophoresis results revealed protein bands of approximately 50 kDa
that correspond to porcine IgG heavy chains and the 25 kDa protein
bands that correspond to porcine IgG light chains. These bands were
present in the partially purified MBL sample in Phase 1 and were virtually
undetectable in the more purified MBL Phase 2 sample. In addition, the
IgG that was removed from the partially purified MBL sample during Phase
2 of the purification process showed bands at both the 50- a n d 25- kDa
location in lane 4. These data support the hypothesis that IgG was
present in the Phase 1 sample and was successfully separated from the
MBL sample during the protein-A chromatography portion of the
purification process. Evidence that the IgG was captured was supported
by anti-porcine IgG ELISA analysis. Results showed that there was a high
degree of IgG present in the Phase 1 sample and the Phase 2-lgG sample.
In addition, IgG was only present at very low levels in the Phase 2 MBLcontaining sample, once again indicating that IgG was extracted from
the Phase 2 sample. Our findings verified that a protein A column is an
appropriate and useful step in the purification of MBL from porcine serum.
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CHAPTER TWO

CHAPTER 2

The Role of OmpD in the Adherence of U937 Cells to Salmonella enterica
serovar Typhimurium in the Presence of Mannan-Binding Lectin

ABSTRACT
Author: Terrio, Donna
Type of Publication: Unpublished

The outer membrane porin protein D (OmpD) of Salmonella

enterica

serovar Typhimurium has been found to be a ligand for the human
macrophage cell line, U937. For comparison purposes, bacterial binding
assays were performed using Salmonella enterica Serovar Typhimurium
wild-type and OmpC- and OmpD-deficient bacterial strains. These
experiments were repeated in the presence of either porcine MBL (pMBL)
or human MBL (hMBL). It was observed that binding of the U937 cells to
wt a n d the ompC mutant strain increased when organisms were
preopsonized with hMBL or pMBL. Ten-fold increases in human or porcine
MBL concentrations induced increased binding activity in a doseresponsive manner in the wt strain, but had little effect on the ompD
mutant strain, Inhibition assays using an anti-MBL monoclonal antibody
supported these results. We conclude that OmpD mediates the
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attachment to U937 cells and that both human and porcine MBL
facilitates adherence.

INTRODUCTION

Evidence suggests that outer membrane porin proteins are key
surface- associated molecular complexes involved in initial recognition of
pathogens by host cells (3,10,18,22,35). Understanding the mechanisms
by which Salmonella stimulates host cellular responses in the initial stages
of infection will aid us in the development of novel therapeutic drugs. In
addition, studies in this area may lead to a deeper understanding of the
biological bases of persistent infection commonly observed with a variety
of Salmonella serotypes. The studies outlined here were designed to test
the following hypotheses: 1) Mannan-binding lectin (MBL) enhances the
binding of macrophages to Salmonella Typhimurium; and, 2) The outer
membrane protein OmpD plays a role in the adherence of macrophages
to S. typhimurium in the presence of MBL.

Salmonella express many different outer membrane proteins, including
OmpC (-36 kDa), OmpF (-35 kDa) and in some serovars such as
Salmonella Typhimurium, OmpD (-34 kDa) (7). The relative amounts of
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OmpC, OmpF, and OmpD changes in response to various environmental
conditions. For example, under anaerobic conditions OmpD expression is
up-regulated, while OmpC is down-regulated (47).
Previous studies in our lab have shown that OmpC in Salmonella
Typhimurium is a ligand tor macrophage recognition in the mouse model
(31). However, it was unknown whether OmpC is a ligand in certain
human macrophage cell lines. Further studies in our lab showed that
OmpD but not OmpC was a ligand for macrophage recognition using
U937 cells - a human macrophage cell line (Hara-Kaonga and Pistole,
2004). The present project extended these studies to include the effects
of human or porcine mannan-binding lectin on this system.

MBL binds to mannose O-polysaccharides found on the cell surface of
Salmonella via a carbohydrate recognition domain (CRD). The spacing
and orientation of the CRD defines what ligands the protein can target
(8,26). MBL binds to Salmonella by means of a pattern-recognition mode
of detection (4,25). Thus, MBL recognizes and binds to the specific three
dimensional pattern formed by the repeating oligosaccharide units,
thereby initiating contact with Salmonella. In vitro, MBL seems to
recognize purified components of micro-organisms; however, the
relationship between binding to these isolated
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components does not always correlate with binding to the whole
organism (1). It is possible that these components are released to block
attachment of MBL to the whole organism (18). In addition, MBL does not
always bind to organisms that contain mannose (2,9). These data suggest
that there are other key factors involved in adherence. The majority of
our knowledge is through empirical evidence, with a number of
publications identifying organisms that bind MBL and a few studies that
have explored how changes in the microbial surface alter MBL binding
(4,7,9). We cannot currently predict the microbial targets of MBL binding,
other than testing organisms with very high mannose (or N- acetyl-Dglucosamine or similar) glycans on their surface. For this reason,
Salmonella Typhimurium is a model organism, since it is rich in cell-surface
mannose carbohydrates.
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MATERIALS AND METHODS

Chemicals. All chemicals used were obtained from EM Science,
Gibbstown, NJ, except where otherwise noted.

Abbreviations. Phosphate-buffered saline (PBS), Hanks Balanced Salt
solution (HBSS), Luria-Bertani (LB) broth and agar, Fetal bovine serum
(FBS), phorbol 12-myristate 13-acetate (PMA).

Bacterial Strains and Growth Conditions. Salmonella Typhimurium strain
14028 (ATCC) was used. The OmpC mutant (BHKC1) and OmpD mutant
(BHKD1) were created by transposon mutagenesis in the 14028 parent
strain (Hara-Kaonga a n d Pistole, 2004) (see table 2.1). The 3 strains were
each grown anaerobically, under non-agitating conditions, in 50 ml of LB
broth for ~8 h at 37°C a n d diluted 1: 20 in LB broth. The diluted culture was
incubated anaerobically, without shaking, for 14-16 h at 37°C. The
bacteria in the logarithmic phase were harvested by centrifugation at
9,000 x g at 4°C for 10 minutes, washed three times with PBS a n d
resuspended in 5 ml of HBSS. Bacterial concentrations were measured
using a spectrophotometer at 600 nm. These concentrations were
confirmed by serial plating on LB agar. Colonies were counted visually.
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Table 2.1. Bacterial Strains used.

Strain of
Salmonella enterica
serovar Typhimurium

Genotype

Source

14028

smooth wild-type

ATCCQ

BHKC1

ompC::Tn/0

Hara-Kaonga and
Pistole. (29)

BHKC2

ompD::Tn5

Hara-Kaonga and
Pistole. (29)

a

American Type Culture collection
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Macrophages. U937 cells obtained from ATCC were cultured in RPMI
1640 medium (ATCC) supplemented with 10% FBS at 37°C, 5% C0 2 . Cell
viability was determined by trypan blue exclusion. U937 cells, -5.0 x 107
cells per T75 flask, were treated with PMA (10 ng/ml) to promote
differentiation and adherence and incubated overnight at 37°C, 5% CO2.

Human Mannan-binding Lectin (hMBL). hMBL was obtained from US
Biologies, Swampscott, MA.

Anti- porcine mannan-binding lectin antibody. Anti- porcine MBL
monoclonal antibody was obtained from Chemicon International, Inc.,
Temecula, CA.

Binding Assays: The PMA-treated U937 cells were centrifuged at 800 x
g for 10 min. and the pellet was resuspended in fresh medium (RPMI 1640,
10% FBS) without PMA, then added to a series of 8-well chambered slides
(Nunc, Kamstrup, Denmark).

After a 2 hour incubation at 37°C, 5% CO2, the U937 cells were washed
with PBS, then separately incubated with the three S. Typhimurium strains
(wild-type, ompC mutant, ompD mutant) at the following
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macrophage/bacteria ratios: 1:10,1:100,1:500. This was done as a
preliminary study to determine an optimum bacterial/macrophage ratio.
Subsequent experiments were performed using 1:10 ratio only.

The assay was then repeated as above, with one additional step. Prior
to adding the bacteria to the U937 cells in the chambered slides, the
bacteria were first mixed with either porcine MBL or human MBL at
increasing concentrations then incubated for 1 hour at 4°C. The MBL
concentrations were as follows: 0.03 gg/ml, 0.30 MQ/nnl, and 3.0 |jg/ml.
After washing the chambered slides containing the U937 cells with HBSS,
the varying bacteria/MBL concentrations were added to the wells (see
table 2.2) and incubated for 2 hours at 37°C. Slides were fixed and
stained and the mean number of attached bacteria per macrophage
was determined by counting the number of adherent cells by light
microscopy.
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Table 2.2. Contents of the various wells in the dose response binding
assays. The gray shaded areas were the controls.

wt
14028

U937

Weil#

OmpC
mutant

OmpD
mutant

Porcine
MBL
(Mg/ml)

Human
MBL
(pg/mi)

1

+

2

+

+

3

+

+

0.03

4

+

+

0.30

5

+

+

3.00

6

+

+

0.03

7

+

+

0.30

8

+

+

3.00

9

+

+

10

+

+

11

+

+

0.30

12

+

+

3.00

13

+

+

0.03

14

+

+

0.30

15

+

+

3.00

16

+

+

17

+

+

0.03

18

+

+

0.30

19

+

+

3.00

20

+

+

0.03

21

+

+

0.30

22

+

+

3.00
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0.03

Inhibition Assays: U937 cells were stimulated with PMA and incubated
in 8-well plates as described previously. Aliquots of porcine MBL and
human MBL were prepared and the concentrations of each were
adjusted to 3 M9/ml. Anti-MBL antibody was diluted to 1 pg/ml and twofold dilutions were prepared, beginning with the 1 ug/ml concentration.
The serial dilutions were a d d e d to porcine MBL or human MBL in separate
tubes and incubated for 1 hour at 4°C. 500 pi of either Salmonella wt (107
CFU), the ompD mutant (TO7 CFU), or the ompC mutant (107 CFU), were
a d d e d separately to 500 u.1 of each of the human MBL/anti-MBL dilutions,
and incubated for 1 hour at 4°C. This step was repeated, but this time the
bacteria were a d d e d to the porcine MBL/anti-MBL dilutions. Each assay
was performed in duplicate and repeated three times. The assay
involving the o m p C mutant was performed in duplicate only. Controls
were also included (see table 2.3). Bacterial concentrations were
confirmed by serial plating on LB agar.
The 8-well slides containing the U937 cells were washed with HBSS two
times and the two bacterial strains, previously incubated with either
human MBL or porcine MBL at varying ratios, were a d d e d separately to
the wells and incubated for two hours at 37°C, 5% CO2. The wells were
washed 3-4 times with HBSS. Slides were fixed and stained and adherent
cells were measured by light microscopy.
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Table 2.3. Contents of the various wells in the inhibition assays.
The gray shaded areas were the controls.

wt
14028

U937

Well*

OmpD
mutant

Porcine
MBL

Human
MBL

Anti-MBL
(ratio 1 :x)

1

+

2

+

+

3

+

+

+

4

+

+

+

1,000

5

+

+

+

2,000

6

+

+

+

4,000

7

+

+

+

8,000

8

+

+

+

16,000

9

+

+

+

10

+

+

+

1,000

11

+

+

+

2,000

12

+

+

+

4,000

13

+

+

+

8,000

14

+

+

+

16,000

15

+

+

16

+

+

+

17

+

+

+

1,000

18

+

+

+

2,000

19

+

+

+

4,000

20

+

+

+

8,000

21

+

+

+

16,000

22

+

+

+

23

+

+

+

1,000

24

+

+

+

2,000

25

+

+

+

4,000

26

+

+

+

8,000

27

+

+

+

16,000
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RESULTS

Binding activity of Mq> to Salmonella in the presence of MBL. In this
study, a series of binding assays was performed to determine the effect of
porcine MBL on the adherence of macrophages to Salmonella
Typhimurium and two mutant strains. The results were then compared to
those obtained when the bacteria were pre-incubated with human MBL.
There were clear differences in binding activity between the three strains.
Binding activity is illustrated in Fig. 2.1 - 2.7.

Studies involving ten-fold increases in hMBL or pMBL concentrations
showed increased binding activity in a dose-responsive manner in both
the wt and ompC mutant strains (Fig. 2.1 and Fig. 2.2). When the wt strain
was preopsonized with 0.03 pg/ml hMBL it resulted in 32% adherence; tenfold increases in MBL concentrations resulted in 42% and 84% adherence,
respectively. Preopsonization with 0.03 u.g/ml pMBL resulted in 30%
adherence; ten-fold increases in MBL concentrations resulted in 32% and
67% adherence, respectively. Results were similar when using the ompCmutant strain. When the ompC mutant was preopsonized with 0.03 \ig/rr\\
hMBL it resulted in 34% adherence; ten-fold increases in MBL
concentrations resulted in 42% and 87% adherence, respectively.
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Preopsonization with 0.03 ug/ml pMBL resulted in 30% adherence; ten-fold
increases in MBL concentrations resulted in 34% and 67% adherence,
respectively. There was very little change in binding activity with the
ompD mutant preopsonized with either pMBL or hMBL at any
concentration of MBL. The ompD mutant resulted in 8% adherence with
MBL concentrations up to 3.0 pg/ml.
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Fig. 2.1. Wt binding activity in response to increased concentrations of
MBL. Bacteria (5 x 107 CFU/ml) were incubated with increasing
concentrations of MBL: 0.03 pg/ml; 0.3 |jg/ml; 3 ug/ml for 1 h at 37°C. With
the wt strain, there was increased binding activity in a dose-responsive
fashion as the concentration of human or porcine MBL increased. There
was not a significant increase in binding between 0.03-0.30 (jg/ml;
however there was a sharp increase in adherence at 3.0 pg/ml.
Preopsonization with 0.03 pg/rnl human MBL resulted in 32% adherence;
10-fold increases in MBL concentrations resulted in 42% and 84%
adherence, respectively. Preopsonization with 0.03 pg/ml porcine MBL
resulted in 30% adherence; 10-fold increases in MBL concentrations
resulted in 32% a n d 67% adherence, respectively. Each data point
represents the mean ± SD of two separate experiments performed in
duplicate.
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Fig. 2.2. OmpC mutant binding activity in response to increased
concentrations of MBL. Bacteria (5 x 107 CFU/ml) were incubated with
increasing concentrations of MBL: 0.03 pg/ml; 0.30 ug/ml; 3.0 ug/ml for 1 h
at 37°C. With the ompC mutant strain, there was increased binding
activity in a dose-responsive fashion as the concentration of human or
porcine MBL increased. There was not a significant increase in binding
between 0.03-0.30 ug/ml; however there was a sharp increase in
adherence at 3.0 ug/ml. Preopsonization with 0.03 ug/ml human MBL
resulted in 34% adherence; 10-fold increases in MBL concentrations
resulted in 42% and 87% adherence, respectively. Preopsonization with
0.03 ug/ml porcine MBL resulted in 30% adherence; 10-fold increases in
MBL concentrations resulted in 34% a n d 68% adherence, respectively.
Each data point represents the mean ± SD of two separate experiments
performed in duplicate.
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There was high binding activity of U937 cells to both the wt and ompC
mutant strains when organisms were preopsonized with 3.0 ng/ml of hMBL
or pMBL. When either bacterial strain was incubated with macrophages
only (no MBL present) the binding activity averaged approximately 32%.
There was a dramatic increase in binding when the wt strain was
incubated with either human or porcine MBL, with 82% and 69%
adherence respectively (fig. 2.3). There were similar results when the
ompC mutant was incubated with either human or porcine MBL (fig. 2.4.)
Binding activity more than doubled, with 66% adherence in the presence
of pMBL and 84% adherence in the presence of hMBL. These results
contrasted sharply when compared to the OmpD-deficient strain. There
was minimal binding activity with the OmpD mutant strain in the presence
of either human or porcine MBL, with only 8% adherence when incubated
with either MBL species. There was no significant difference when
comparing these results to the control, (no MBL) which exhibited 6%
adherence.

46

Salmonella Wild-Type Binding Activity
ou

T
80
70

o
o

% Binding

60

30 -

T

• •

20 10 n

% Binding

wt/Mcp

wt/Mcp/ pMBL

wt/Mcp/ hMBL

30

69

82

Fig. 2.3. Binding to U937 cells by Salmonella wt incubated with 3.0 pg/ml of
either human MBL or porcine MBL. There was increased bacterial binding
to U937 cells in the presence of 3.0 pg/ml of either pMBL or hMBL, with 69%
adherence in the presence of pMBL and 82% adherence in the presence
of hMBL. The control, without added MBL exhibited 30% adherence.
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Salmonella omp C mutant Binding
Activity
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Fig. 2.4. Binding to U937 cells by the Salmonella ompC mutant strain
incubated with 3.0 Mg/ml of either human MBL or porcine MBL There was
increased bacterial binding to U937 cells in the presence of 3.0 pg/ml of
either pMBL or hMBL There was 66% adherence in the presence of pMBL
and 84% adherence in the presence of hMBL. The control, without added
MBL, exhibited 28% adherence.
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Salmonella omp D mutant Binding Activity
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Fig. 2.5. Binding to U937 cells by the Salmonella ompD mutant strain
incubated with 3.0 pg/ml of either human MBL or porcine MBL. There was
no statistical difference in bacterial binding to U937 cells when the ompDdeficient strain was incubated in the presence of 3.0 pg/ml of either pMBL
or hMBL or when incubated without MBL When the ompD mutant was
incubated without MBL there was 6% adherence. There was 8%
adherence in the presence of pMBL or hMBL.
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The following two bar graphs (figs. 2.6 and 2.7) depict the same data
that were presented in the previous three graphs, but emphasizing the
bacterial strains as the variable, rather than the presence or absence of
MBL.
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Binding Activity of 3 Salmonella Sfrains in the
presence of pMBL
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Fig. 2.6. Salmonella wild-type, ompC mutant and ompD mutant strains
incubated with porcine MBL There was increased binding activity with
the wt and ompC mutant strains in the presence of pMBL, with 69% a n d
66% adherence respectively. There was 8% adherence with the ompDdeficient strain in the presence of pMBL.
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Binding Activity of 3 Salmonella Strains in the
Presence of hMBL
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Fig. 2.7. Salmonella wild-type, ompC mutant and ompD mutant strains

incubated with human MBL There was increased binding activity with the
wt and ompC mutant strains in the presence of hMBL, with 82% and 84%
adherence respectively. There was 8% adherence with the ompDdeficient strain when incubated with hMBL

52

The effects of inhibition of MBL on Salmonellae adherence to U937
Cells. We examined the inhibitory potential of anti-porcine MBL
monoclonal antibody toward both human or porcine MBL a n d its effects
on bacterial adherence to macrophages. Since very little binding activity
was observed when the ompD mutant was incubated with the U937 cells,
with or without either pMBL or hMBL, it was expected that there would be
little to no change in the ompD mutant binding activity when the anti-MBL
antibody was a d d e d .

PMA-stimulated U937 cells were incubated with Salmonella wt, ompC
mutant or ompD mutant strains. Two-fold dilutions of anti-MBL antibody
were incubated with either porcine or human MBL. Finally, either the wt,
ompC, or ompD mutant strains were incubated separately with each of
the hMBL/anti-MBL or pMBL/anti-MBL dilutions. Increased binding activity
was observed in the wt strain as the anti-MBL concentrations decreased,
until it reached a plateau between the 1:8k and 1:16k dilution in the
presence of either pMBL or hMBL. The two negative controls (-pMBL/antibody; -hMBL/-antibody) showed 29% and 32% adherence
respectively. The two positive controls {+pMBL/-antibody; +hMBL/antibody), showed 64% and 87% binding, respectively. Figure 2.8 shows
the % binding activity that occurred in the presence of either pMBL or
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hMBL at the different anti-MBL dilutions.

A similar trend was observed in the ompC mutant strain, i.e., as the
anti-MBL concentrations decreased adherence increased. The two
negative controls (-pMBL/-antibody; -hMBL/-antibody) showed 30% and
32% adherence respectively. The two positive controls (+pMBL/-antibody;
+hMBL/-antibody), showed 68% and 86% binding, respectively.

The ompD mutant strain showed no difference in adherence to U937
cells in the presence of decreasing concentrations of anti-MBL. The
binding activity was similar to the results in the binding assays performed
without MBL, i.e., approximately 6%-8%. The two negative controls
(-pMBL/-antibody; -hMBL/-antibody) showed 8% a n d 6% adherence
respectively. The two positive controls (+pMBL/-antibody; +hMBL/antibody), both showed 8% adherence (fig. 2.10).

54

Effects of Inhibition of MBL on WT adherence
to U937 Cells

i
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Fig. 2.8. The effects of inhibition of MBL on wt adherence to U937 cells.
Increased binding activity was observed in the wt strain as the anti-MBL
concentrations decreased, until it reached a plateau between the 1:8k
and 1:16k dilution in the presence of either pMBL or hMBL. The two
negative controls (-pMBL/-antibody; -hMBL/-antibody) showed 29% and
32% adherence respectively. The two positive controls (+pMBL/-antibody;
+hMBL/-antibody), showed 64% and 87% binding, respectively.

Effects of Inhibition on Adherence of ompC mutant to
U937 Cells
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Fig. 2.9. The effects of inhibition of MBL on ompC- deficient Salmonella
adherence to U937 cells. Increased binding activity was observed in the
ompC- deficient strain as the anti-MBL concentrations decreased, until it
reached a plateau between the 1:8k and 1:16k dilution in the presence of
either pMBL or hMBL. The two negative controls (-pMBL/-antibody; hMBL/-antibody) showed 30% and 32% adherence respectively. The two
positive controls (+pMBL/-antibody; +hMBL/-antibody), showed 68% and
86% binding, respectively.
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Effects of Inhibition on Adherence of ornpD mutant to
U937 Cells
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Fig. 2.10. The effects of inhibition of MBL on ornpD- deficient Salmonella
adherence to U937 cells. The ompD mutant strain showed no difference
in binding activity as the anti-MBL concentrations decreased in the
presence of either pMBL or hMBL. The two negative controls (-pMBL/antibody; -hMBL/-antibody) showed 8% and 6% adherence respectively.
The two positive controls (+pMBL/-antibody; +hMBL/-antibody), both
showed 8% adherence.
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DISCUSSION
The role of OmpD in pathogenesis has been widely questioned for
many years. Some studies have shown that certain ompD- deficient
Salmonella strains were less virulent than the wild-type parent strains, while
others have reported that there is no difference in virulence (11,12,29,30).
Previously in our lab it was shown that OmpD was involved in adherence
of Salmonella Typhimurium 14028 to macrophages (29,30). Our present
data also show that there was a difference between the abilities of two
different Salmonella omp- deficient strains and their parent strain to bind
to U937 cells under anaerobic conditions. In addition, there was virtually
no difference in binding activity in the presence of either porcine or
human MBL with the ompD mutant strain.
There are many possible explanations for these results. During the
infection process Salmonella is exposed to many extreme environmental
changes, including variations in O2 levels and pH, and consequently have
developed various strategies to survive these changes (7,12). Under
aerobic conditions OmpD is the primary porin present in Salmonella wildtype cells, in approximately 1 * 105 porin molecules per cell (47).
Collectively, OmpD, OmpC, and OmpF are present in approximately
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2 x TO5 porin molecules per cell (47). Conversely, under anaerobic
conditions the amount of OmpD porin molecules almost doubles when
compared to the expression of other outer membrane proteins, which
either decrease or remain relatively stable in quantity (47). It is possible
that when the OmpD porin is eliminated the cell surface has altered in
such a way that it no longer allows binding of the OmpD to the U937 cell
line. Since OmpD is the major porin protein present in Salmonella wildtype cells, its deletion would drastically change the overall protein
framework of the outer membrane. In addition, LPS and porins are so
tightly associated that it is extremely difficult to separate the two during
purification processes (26). Thus, the deletion of one may significantly
affect the other. For example, Koplow and Goldfine (44) found that levels
of major outer membrane proteins were drastically decreased in S.
Typhimurium mutants expressing very defective LPS. This external
structural change caused the mutants to b e c o m e very sensitive to certain
hydrophobic substances. Conversely, when an outer membrane porin is
eliminated it is possible that the LPS may be defective. This could also
explain why MBL had very little effect on ompD adherence. Since MBL
binds to Salmonella by means of a pattern-recognition mode of detection
(4,25,26) a n d the spacing and orientation of the CRD defines what ligands
MBL can target (7,28), then it would follow that if the LPS has been altered
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then binding may be greatly affected.

The two MBL species showed different levels of binding activity.
Although the wt and ompC mutant strains showed increased adherence
as the human or porcine MBL concentrations increased, pMBL had less
effect than hMBL. Human and porcine MBL share approximately 67%
homology (20). Although this percentage is relatively high there is also a
33% difference. Human MBL may possess one or more epitopes that
recognize certain surface molecules on Salmonella that pMBL does not.
The presence of such an epitope may assist in the binding process and
therefore result in higher binding activity. There was a difference
between the two MBL species in the amount of binding observed;
however, as mentioned previously there were similarities in the overall
patterns in adherence, ie., binding increased as the MBL concentrations
increased. Based on these results, it appears that both human MBL and
porcine MBL have analogous effects on Salmonella adherence to U937
cells.

The porcine MBL was purified by using a multi-step chromatography
process. The second phase involved a protein A column. This method
was a novel approach and based on SDS-PAGE and ELISA results,
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appears to have successfully separated the IgG from the MBL. However,
the purified porcine MBL sample may have contained a small amount of
residual protein. To further verify the purity of the sample, we would
suggest that additional tests be performed in the future, such as mass
spectrometry and/or genetic testing. The results of these tests may
warrant the addition of a third phase in the purification process, such as
ion-exchange chromatography or chromatofocusing.

We conclude that both human and porcine MBL are opsonins that are
able to increase macrophage binding to Salmonella in a dosedependent fashion. In addition, our results suggest that the outer
membrane protein porin D of Salmonella wild-type strain 14028, is a ligand
for adherence to the macrophage cell line U937.
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